New drug duo tested in fight against aggressive breast cancer
Disease control
ENROLLING_BY_INVITATION
This study is testing whether combining two existing drugs, sacituzumab govitecan and bevacizumab, can help control advanced triple-negative breast cancer that has spread. It is for people whose cancer has worsened after at least one prior treatment. The main goals are to see if …
Phase: PHASE2 • Sponsor: YING FAN • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC